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NOTCH-mediated non-cell autonomous regulation
of chromatin structure during senescence
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Senescent cells interact with the surrounding microenvironment achieving diverse functional
outcomes. We have recently identiﬁed that NOTCH1 can drive ‘lateral induction’ of a unique
senescence phenotype in adjacent cells by speciﬁcally upregulating the NOTCH ligand JAG1.
Here we show that NOTCH signalling can modulate chromatin structure autonomously and
non-autonomously. In addition to senescence-associated heterochromatic foci (SAHF),
oncogenic RAS-induced senescent (RIS) cells exhibit a massive increase in chromatin
accessibility. NOTCH signalling suppresses SAHF and increased chromatin accessibility in
this context. Strikingly, NOTCH-induced senescent cells, or cancer cells with high JAG1
expression, drive similar chromatin architectural changes in adjacent cells through cell–cell
contact. Mechanistically, we show that NOTCH signalling represses the chromatin archi-
tectural protein HMGA1, an association found in multiple human cancers. Thus, HMGA1 is
involved not only in SAHFs but also in RIS-driven chromatin accessibility. In conclusion, this
study identiﬁes that the JAG1–NOTCH–HMGA1 axis mediates the juxtacrine regulation of
chromatin architecture.
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Cellular senescence is an autonomous tumour-suppressormechanism that can be triggered by pathophysiologicalstimuli including replicative exhaustion, exposure to che-
motherapeutic drugs and hyper-activation of oncogenes, such as
RAS1. Persistent cell cycle arrest is accompanied by diverse
transcriptional, biochemical and morphological alterations. These
senescence hallmarks include increased expression and secretion
of soluble factors (senescence-associated secretory phenotype
(SASP))2,3 and dramatic alterations to chromatin structure1,4,5.
Importantly, the combination, quantity and quality of these fea-
tures can vary depending on the type of senescence. Senescent
cells have profound non-cell autonomous functionality. The
SASP can have either protumorigenic or antitumorigenic effects
and act in an autocrine or paracrine fashion2,6–8. In addition, we
have recently identiﬁed that NOTCH signalling can drive a cell-
contact-dependent juxtacrine senescence9.
The NOTCH signalling pathway is involved in a wide array of
developmental and (patho-)physiological processes. NOTCH has
roles in differentiation and stem cell fate10 and perturbations have
been linked to tumorigenesis where NOTCH can have either
oncogenic or tumour-suppressive functionality11. The pathway
involves proteolytic cleavage of the NOTCH receptor upon
contact-mediated activation by a ligand of the JAGGED (JAG) or
DELTA family on the surface of an adjacent cell. The cleaved
NOTCH-intracellular domain translocates to the nucleus where,
together with transcriptional co-activators such as mastermind-
like 1 (MAML1), it drives transcription of canonical target genes,
including the HES and HEY family of transcription factors10.
NOTCH signalling has also been shown to induce a type of
senescence, NOTCH-induced senescence (NIS), where cells are
characterised by distinct SASP components9,12. Recently, we
showed that during NIS there is a dramatic and speciﬁc upre-
gulation of JAG1 that can activate NOTCH1 signalling and drive
NIS in adjacent cells (‘lateral induction’)9.
During senescence, particularly in oncogenic RAS-induced
senescent (RIS) ﬁbroblasts, characteristic changes to chromatin
culminate in the formation of senescence-associated heterochro-
matic foci (SAHFs)13, layered structures facilitated by spatial
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Fig. 1 NOTCH1 signalling has a chromatin ‘smoothening’ effect that blocks SAHF. a Diagram illustrating the NOTCH1 signalling pathway, which can be
repressed chemically using DAPT or genetically by expressing dominant-negative MAML1 (dnMAML1). b IMR90 ER:HRASG12V cells were infected with
control vector or N1ICD-FLAG and incubated with ±100 nM 4OHT for 6 days. Representative images of nuclei stained with DAPI for the conditions
indicated (scale bar= 10 µm). Percentage indicates the number of SAHF-positive cells within the population (see d). c, d Quantiﬁcation of nuclear area,
standard deviation of DAPI intensity (c) and the number of SAHF-positive cells (d) for the conditions indicated in b. Lines indicate the mean value of each
replicate. n= 3 (c) and n= 4 (d) biologically independent replicates. Values of individual replicates for nuclear area and standard deviation are shown in
Supplementary Fig. 1b, d. e Time series analysis of SAHF-positive nuclei following the addition of 100 nM 4OHT to IMR90 ER:HRASG12V cells in the
presence or absence of ectopic dnMAML1 or 10 µM DAPT (left). n= 3 biologically independent replicates. Representative DAPI images of the indicated
conditions (+RAS= 7 days of 4OHT treatment; scale bar= 25 µm). c–e Statistical signiﬁcance calculated using one-way ANOVA with Tukey’s correction
for multiple comparisons. *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001
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rearrangement of existing heterochromatin14. Other alterations
include the formation of senescence-associated distention of
satellites (SADS)15.
SAHF formation is dependent on chromatin-bound high-
mobility group A (HMGA) proteins, particularly HMGA116.
These are a family of architectural proteins, consisting of
HMGA1 and HMGA2, which bind to the minor groove of AT-
rich DNA via three AT-hook domains to alter chromatin
structure17,18. Despite a critical role in the formation of SAHFs
during senescence, HMGA proteins are also important during
development where they promote tissue growth19,20 and regulate
differentiation21–24. Furthermore, many studies have demon-
strated an association between high HMGA1 expression and
aggressive tumour biology25,26.
Chromatin accessibility at regulatory elements including pro-
moters and enhancers is highly correlated with biological activ-
ity27. High-throughput sequencing using FAIRE-seq, a method
that identiﬁes open and closed chromatin based on phenol
separation28, has revealed that, in cells that have undergone
replicative senescence, previously heterochromatic domains
enriched for various repeat elements become more accessible
while euchromatic domains undergo condensation29. However, it
remains unknown how chromatin accessibility is altered in RIS
and NIS cells.
Here we characterise the chromatin phenotype in RIS and NIS
cells. We demonstrate that these two types of senescent cells exhibit
distinct chromatin structures at microscopic and nucleosome scales.
Both gain multiple chromatin accessible regions, which are often
exclusive between RIS and NIS. Strikingly, we ﬁnd that autonomous
and non-cell autonomous activation of the NOTCH signalling
pathway in RIS cells can repress SAHFs and the formation of RIS-
driven chromatin-accessible regions, partially by transcriptional
repression of HMGA1. Our study demonstrates that chromatin
structure and the nucleosome landscape can be regulated through
juxtacrine signalling. The relationship between these two prominent
tumour-associated genes, HMGA1 and NOTCH1, may also have
prognostic value in vivo.
Results
NOTCH1 reprogrammes chromatin structure and abrogates
SAHFs. We have previously demonstrated that ectopic
NOTCH1-intracellular domain (N1ICD), an active form of
NOTCH1 (Fig. 1a), can drive NIS that is distinct from RIS in
terms of SASP composition9 and noticed that NIS cells also have
a unique chromatin structure.
To examine the relationship between NOTCH1 and chromatin
structure, we introduced ectopic N1ICD into IMR90 human
diploid ﬁbroblasts (HDFs) stably expressing a 4-hydroxytamoxifen
(4OHT)-inducible oestrogen receptor–oncogenic HRAS fusion
protein (IMR90 ER:HRASG12V cells)30. Ectopic expression of
N1ICD alone induced senescence with dramatically enlarged
nuclei, even larger than in RIS (Fig. 1b, c). Similarly to RIS, NIS
cells formed SADS, a more common chromatin feature of
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Fig. 2 NOTCH1 and JAG1 can non-autonomously repress SAHF formation in adjacent cells. a Schematic showing experimental set-up. IMR90 cells
expressing doxycycline (DOX)-inducible N1ICD-FLAG were cultured with IMR90 ER:HRASG12V cells expressing mRFP with 100 nM 4OHT ± 1000 ng/mL
DOX for 6 days. b Quantiﬁcation of SAHF-positive red cells for the experiment outlined in a. Alone: mono-cultured IMR90 ER:HRASG12V cells; iN1ICD:
DOX-inducible N1ICD-FLAG. c Representative images of co-cultures indicated (scale bar= 25 µm). Insets are unmerged DAPI images of the indicated cells
(arrows). d Schematic showing experimental set-up. IMR90 ER:HRASG12V cells expressing mRFP were co-cultured with RPE1 cells stably expressing either
mVenus or JAG1-mVenus for 6 days ±100 nM 4OHT. e Quantiﬁcation of SAHF-positive red cells for the experiment outlined in d. f Representative images
of co-cultures indicated (scale bar= 25 µm). Insets are unmerged DAPI images of the indicated cells (arrows). Note DAPI foci in RPE1 cells are not SAHFs.
b, e Lines indicate the mean value of individual replicates. n= 3 biologically independent replicates for all conditions. Statistical signiﬁcance calculated using
one-way ANOVA with Tukey’s correction for multiple comparisons; ***p≤ 0.001, NS= not signiﬁcant
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senescence than SAHFs (Supplementary Fig. 1a)15. However, in
marked contrast to RIS, NIS cells lacked SAHFs (Fig. 1b, d).
To ask whether NIS cells simply lack SAHFs or whether
N1ICD actively modulates chromatin structure, we expressed
N1ICD in the presence of HRASG12V induced using 100 nM of
4OHT for 6 days. Interestingly, N1ICD in the context of RIS also
resulted in a dramatic enlargement of nuclei but a complete
ablation of SAHF formation (Fig. 1b–d). This was emphasised by
a ‘smoothening’ of chromatin as indicated by a marked reduction
in the standard deviation of 4,6-diamidino-2-phenylindole
(DAPI) signal measured within individual nuclei (Fig. 1b, c;
Supplementary Fig. 1b-d), We have previously shown that ectopic
N1ICD in the RIS context results in senescence with SASP
composition broadly similar to NIS9. Thus our data indicate that
NOTCH is dominant over RIS in terms of chromatin phenotype
as well as SASP composition.
In IMR90 ER:HRASG12V cells, RIS develops progressively over
a time period of ~6 days following the addition of 4OHT30.
NOTCH1 signalling is temporally regulated during RIS, where
cleaved and active N1ICD is transiently upregulated before
downregulation at full senescence9. To examine the temporal
effects of NOTCH1 signalling on SAHF formation, we performed
a time course experiment in IMR90 ER:HRASG12V cells. Cells
were retrovirally infected with a dominant-negative form of
MAML1 fused to mVenus (dnMAML1-mVenus) or treated with
the γ-secretase inhibitor N-[(3,5-diﬂuorophenyl)acetyl]-L-alanyl-
2-phenyl]glycine-1,1-dimethylethyl ester (DAPT) to repress
downstream signalling by N1ICD (Fig. 1a). We found that a
greater number of SAHF-positive cells were formed and that
these accumulated at earlier time points when
NOTCH1 signalling was repressed (Fig. 1e). Furthermore, a
dose-dependent effect was evident where higher concentrations of
DAPT resulted in a greater proportion of cells developing SAHF
during RIS (Supplementary Fig. 1e). SAHFs are not typically
prominent in DNA damage-induced senescence (DDIS) in
IMR90 cells1. However, DAPT signiﬁcantly promoted SAHF
formation in DDIS (by etoposide) (Supplementary Fig. 1f). To
determine whether NOTCH1 activity can reverse SAHF after they
have formed, we infected IMR90 cells with doxycycline (DOX)-
inducible N1ICD-FLAG and constitutive HRASG12V. The addi-
tion of DOX after the establishment of senescence was sufﬁcient
to reduce the number of SAHF-positive cells and the standard
deviation of DAPI signal, suggesting some degree of reversibility
(Supplementary Fig. 1g). Together, our data suggest that NOTCH
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signalling has a chromatin ‘smoothening’ effect that antagonises
SAHF formation.
Non-cell autonomous regulation of SAHFs. N1ICD-expressing
cells can induce NIS in adjacent normal cells, at least in the case
of IMR90 ﬁbroblasts9. To determine whether N1ICD-expressing
cells can also alter chromatin structure in adjacent cells, we
performed co-cultures between mRFP1-expressing IMR90 ER:
HRASG12V and IMR90 cells expressing DOX-inducible N1ICD-
FLAG in the presence and absence of 4OHT and DOX (Fig. 2a).
Strikingly, co-culture with N1ICD-expressing IMR90 cells was
sufﬁcient to repress SAHF formation in adjacent RIS (red) cells
(Fig. 2b, c).
Of the canonical NOTCH1 ligands, we have previously
observed a strong and unique upregulation of JAG1 following
ectopic N1ICD expression, which we found to be responsible for
the juxtacrine transmission of NIS9. We reasoned that N1ICD-
mediated upregulation of JAG1 and subsequent ‘lateral induction’
of NOTCH1 signalling is a likely mechanism by which SAHFs are
regulated non-autonomously. To test this hypothesis, we
expressed ectopic JAG1 fused to mVenus (JAG1-mVenus) in
retinal pigment epithelial (RPE1) cells. We conﬁrmed cell surface
expression of ectopic JAG1 by ﬂow cytometry (Supplementary
Fig. 2a) before co-culturing with mRFP1-expressing IMR90 ER:
HRASG12V cells. RPE1 JAG1-mVenus cells, but not control
RPE1 cells, signiﬁcantly repressed the formation of SAHFs
(Fig. 2e, f). Note that this repression did not occur when these two
types of cells were co-cultured without physical contact in a
transwell format (Supplementary Fig. 2b). Our data suggest a
mechanism by which lateral induction of NOTCH signalling
by JAG1 can block SAHFs in the context of RIS; i.e. higher-
order chromatin structure can be regulated through cell–cell
contact.
NOTCH signalling represses the expression of HMGA genes.
To unravel the mechanisms underpinning NOTCH1-dependent
repression of SAHFs, we re-analysed previously published RNA-
seq data generated from IMR90 cells expressing HRASG12V and
N1ICD9. We found that N1ICD dramatically represses the
expression of HMGA1 and HMGA2 (Supplementary Fig. 3a),
critical components of SAHF structure16.
To validate that NOTCH1 signalling represses HMGAs, we
introduced constitutive N1ICD into IMR90 ER:HRASG12V cells.
Ectopic N1ICD signiﬁcantly repressed HMGA1 and HMGA2 at
an mRNA and protein level in both the presence and absence of
4OHT-induced HRASG12V (Fig. 3a, b). The enforced expression
of N1ICD after senescence establishment also resulted in the
reduction of HMGA1 albeit to a lesser extent than pre-senescence
N1ICD expression (Supplementary Fig. 1g). N1ICD has a similar
effect on HMGA1 and 2 protein levels when expressed in other
cell lines in the absence of HRASG12V, suggesting a conserved
mechanism (Supplementary Fig. 3b). In the DOX-inducible
N1ICD-FLAG system, inhibition of NOTCH1 signalling by co-
expression of dnMAML1-mVenus was sufﬁcient to rescue
N1ICD-mediated repression of HMGA1 and HMGA2 (Fig. 3c,
d), suggesting the effect is dependent on the canonical pathway of
NOTCH signalling.
Finally, we used IMR90 ER:HRASG12V cells expressing DOX-
inducible N1ICD-FLAG to investigate whether ectopic re-
expression of EGFP-tagged HMGA1 is sufﬁcient to rescue
SAHFs. The introduction of EGFP-HMGA1 resulted in a partial,
but signiﬁcant, rescue of SAHF-positive cells when cells were
treated with DOX and 4OHT (Fig. 3e).
Collectively, our data suggest that NOTCH1 signalling
represses the formation of SAHFs at least partially by inhibiting
HMGAs.
Non-cell autonomous inhibition of HMGAs. To determine
whether HMGAs are repressed non-autonomously by JAG1
expressing cells, we performed further co-cultures between
RPE1 cells retrovirally infected with JAG1-mVenus and IMR90
cells ectopically expressing a cell surface marker, rat-Thy1,
allowing for subsequent isolation using magnetic-activated cell
sorting (MACS) (Fig. 3f). As expected, IMR90 cells co-cultured
with JAG1-expressing cells upregulated canonical NOTCH1 tar-
get genes, HEY1 and HEYL. Both HMGA1 and HMGA2 were
signiﬁcantly repressed in the same IMR90 cells (Fig. 3f),
demonstrating that HMGA proteins can be repressed non-cell
autonomously.
Altered chromatin accessibility in RIS and NIS. To investigate
whether NOTCH1 inﬂuences chromatin structure at a higher
resolution, we employed ATAC-seq (assay for transposase-
accessible chromatin using sequencing)31. This method exploits
a hyperactive Tn5 transposase that inserts sequencing adapters
into regions of accessible chromatin. Following adapter-primed
PCR ampliﬁcation, these regions were sequenced to identify
accessible regions of chromatin genome wide (Fig. 4a).
We generated at least three replicates from IMR90 ER:
HRASG12V cells expressing N1ICD-FLAG or a control vector
and induced with 4OHT or not. For simplicity, these conditions
were labelled as ‘Growing’, ‘RIS’, ‘NIS’ and ‘N+RIS’ (expressing
both N1ICD and RAS). Using a previously published normal-
isation approach32, we generated normalised coverage ﬁles that
appeared comparable to each other, especially around house-
keeping genes (Fig. 4b). Most of the samples, excluding a single
replicate from the NIS and N+RIS conditions (which were
excluded from downstream analysis), were of high quality with a
‘reads in peaks’ percentage (RiP%) of >10% (Supplementary
Fig. 4a). Replicates clustered well by unbiased principal
component analysis (PCA) (Supplementary Fig. 4b). Moreover,
our samples clustered with publically available ATAC-seq and
DNase-seq data generated from IMR90 cells (Supplementary
Fig. 4c), but separated from other cell types (BJ, HaCaT,
MCF710A and HEKn cells).
Using MACS peak calling, we found that the number of peaks
identiﬁed in each replicate of a condition was similar and that, in
general, chromatin accessibility was dramatically increased in RIS
(145,649 consensus peaks detected in ≥2 replicates) and NIS cells
(149,877 peaks) relative to growing cells (83,920 peaks)
(Supplementary Fig. 5a). To quantitatively identify regions of
altered accessibility in RIS and NIS cells relative to growing cells,
we performed differential binding analysis using both edgeR33,34
and THOR35 before taking only regions identiﬁed by both
methods for downstream analysis (Supplementary Data 1). Using
this stringent approach, we identiﬁed 44,556 regions that become
signiﬁcantly more accessible (opened) and 9603 regions that
become signiﬁcantly less accessible (closed) in RIS cells relative to
growing cells. In NIS cells, 20,499 regions became more accessible
and 15,444 regions less accessible (Fig. 4c). Despite the robust
gain of chromatin accessibility in both types of senescence, there
were relatively few shared sites (Fig. 4d).
A previous study mapping chromatin accessibility in replica-
tively senescent cells using FAIRE-Seq found that gene-distal
regions, especially repeat regions, become relatively more open
whereas genic regions become closed compared to growing
ﬁbroblasts29. Consistently, regions of increased accessibility in
RIS and NIS cells were enriched at gene-distal sites
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(Supplementary Fig. 5b) with the majority of opened regions
mapping to enhancer, intergenic, intronic and repeat regions
(Fig. 4e). Many of these repeat regions were further annotated as
long interspersed elements, long-terminal repeats, short inter-
spersed elements and simple repeat regions (Supplementary
Fig. 5c, d), although these values may be underestimated due to
the exclusion of multi-mapping reads from our data. Many of the
regions that became less accessible in RIS cells relative to growing
cells were closer to transcriptional start sites (TSSs) (Supplemen-
tary Fig. 5b) and mapped to exons, CpG-islands and untranslated
regions (UTRs) (Fig. 4e). In contrast to replicative senescence29,
regions of decreased accessibility in NIS cells mostly mapped to
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gene-distal elements (Supplementary Fig. 5b, Fig. 4e). Therefore,
while RIS largely mirrors replicative senescence, NIS is char-
acterised by remodelling (both opening and closing) of gene-
distal regions.
Altered accessibility of genes reﬂects expression. Chromatin
accessibility at regulatory elements has been correlated with gene
expression27. To determine whether genic alterations to chro-
matin accessibility in RIS and NIS reﬂects gene expression, we
assigned regions of altered accessibility (opened or closed in RIS
or NIS) to genes if within 500 bp of a TSS (Fig. 4f). On average,
genes that were opened in RIS relative to growing cells were also
transcriptionally upregulated by mRNA-seq in RIS relative to
growing cells (Fig. 4f, top). Genes that were opened in NIS cells
were transcriptionally upregulated in NIS cells, while less acces-
sible genes were transcriptionally repressed (Fig. 4f, bottom).
Consistent with our previous RNA-seq data9, genes that became
more accessible in RIS were signiﬁcantly enriched within gene
ontology (GO) terms such as ‘inﬂammatory response’ and
‘cytokine secretion’, reﬂecting the inﬂammatory secretome pro-
duced by RIS cells (Fig. 4g). Genes that became less accessible in
RIS were enriched within GO terms such as ‘regulation of cell
cycle’ (Fig. 4g), perhaps reﬂecting non-proliferative features of
RIS (although average gene expression of this gene set was not
signiﬁcantly altered). Unbiased motif enrichment analysis
revealed that regions opened in RIS were highly enriched for the
C/EBPβ-binding motif (Supplementary Fig. 5e), consistent with
the important role of C/EBPβ in regulating the inﬂammatory
SASP3. Regions opened in NIS were enriched with the RBP-J-
binding motif (Supplementary Fig. 5 f), a critical DNA-binding
factor downstream of NOTCH signalling11. Normalised ATAC-
seq coverage ﬁles, when viewed using a genome browser (Fig. 4b,
Supplementary Fig. 6a-d), demonstrated increased accessibility
around transcriptionally activated genes. We also noted that,
while the accessibility at many promoters was unaltered in RIS
cells, some transcriptionally activated genes, such as IL1A and
HMGA1, were proximal to enhancer elements that became more
accessible (Fig. 4b, Supplementary Fig. 6a). Together, these data
demonstrate that RIS and NIS cells have unique open chromatin
landscapes and that (gene proximal) alterations reﬂect their
transcriptional landscapes.
NOTCH signalling antagonises chromatin opening in RIS. By
unbiased clustering of ATAC-seq data, we observed a greater
correlation between NIS and N+RIS cells than between RIS and
N+RIS cells (Fig. 5a). This suggests a dominant effect of N1ICD
over RAS on the nucleosome scale, consistent with our previous
observations for SASP components9 and SAHFs (Fig. 1d).
To determine whether NOTCH1 signalling can repress the
chromatin alterations observed in RIS in favour of a ‘NIS-like’
chromatin landscape, we focussed on the 44,556 regions that
became signiﬁcantly more accessible in RIS cells relative to
growing cells (referred to as ‘RIS-driven accessible regions’,
Fig. 4c) and the 20,499 regions that became signiﬁcantly more
accessible in NIS cells relative to growing cells (referred to as
‘NIS-driven accessible regions’, Fig. 4c). By comparing chromatin
accessibility of N+RIS cells with RIS cells we found that
formation of many RIS-driven accessible regions (62.7%) were
repressed by N1ICD expression (Fig. 5b). N1ICD expression also
increased the accessibility of NIS-driven accessible regions
(Fig. 5b). When viewed in the genome browser, it was evident
that N1ICD expression can repress the formation of accessible
regions located at enhancer elements upstream of the HMGA1
promoter in RIS cells (Supplementary Fig. 6a), although we failed
to detect any alterations at the HMGA2 locus (Supplementary
Fig. 6b), providing a potential mechanism for NOTCH1-
mediated repression of HMGA1.
HMGA proteins have previously been shown to affect
chromatin compaction. To determine whether repression of
HMGA1 is a mechanism by which N1ICD can repress formation
of RIS-driven accessible regions, we generated additional ATAC-
seq samples from IMR90 ER:HRASG12V cells expressing a short
hairpin against HMGA116 and treated with 4OHT, hereafter
referred to as ‘RIS+shHMGA1’. By comparing RIS+shHMGA1
with RIS, we identiﬁed 8909 RIS-driven accessible regions that
were dependent on HMGA1 (Fig. 5c). Of these, 69.9% (6168) were
also repressed by N1ICD (Fig. 5d). These analyses illustrate that a
subset of RIS-driven accessible regions can be repressed by N1ICD,
possibly by HMGA downregulation. However, HMGA1 knock-
down was not sufﬁcient to induce the formation of NIS-driven
accessible regions (Fig. 5c), suggesting an HMGA1-independent
mechanism in the formation of these sites. RIS-driven accessible
regions (opened in RIS) were signiﬁcantly more AT-rich than NIS-
driven accessible regions (opened in NIS) or regions with reduced
accessibility (Fig. 5e), supporting the involvement of HMGA1 in
the formation of RIS-driven accessible regions.
To validate the above approach, we used our normalised
coverage ﬁles to perform unbiased k-means clustering centred
around accessible regions that were altered in either RIS or NIS
cells (opened or closed relative to growing cells) (Fig. 5f).
Accessible regions separated into clusters that were dominated by
either the RIS (clusters 1 and 2) or NIS (clusters 3 and 4)
conditions. Strikingly, the signal in RIS-dominated clusters,
cluster 2 in particular, was reduced in the N+RIS and RIS
+shHMGA1 conditions when compared to the RIS condition
(Fig. 5f). Consistently, cluster 2 was more AT-rich than cluster 1
(Fig. 5g), supporting a role for HMGA1. Notably, while peaks in
clusters 3 and 4 were increased in the N+RIS condition, they did
not increase in the RIS+shHMGA1 condition, reinforcing an
HMGA1-independent mechanism of chromatin opening in NIS
(Fig. 5f). Therefore, in line with microscopic SAHF structures,
N1ICD alters chromatin structure in RIS at the nucleosome scale
in part by repressing HMGA1 expression.
Fig. 6 Tumour cells can repress SAHFs and chromatin opening in adjacent RIS ﬁbroblasts. a Normalised mRNA expression values from the Cancer Cell Line
Encyclopedia (CCLE) and immunoblotting of JAG1 in the tumour cell lines indicated. b Quantiﬁcation of SAHFs in IMR90 ER:HRASG12V cells expressing mRFP
co-cultured with the tumour cell lines indicated for 6 days +100 nM 4OHT ± 10 µM DAPT (left) and representative images (right) (scale bar= 25 µm). n= 3
biological replicates except for Hep3B cultures where n= 6. c SAHF quantiﬁcation in IMR90 ER:HRASG12V cells expressing mRFP+100 nM 4OHT±10 µM
DAPT. d Schematic showing experimental set-up. IMR90 ER:HRASG12V cells expressing mRFP were cultured with tumour cell lines +100 nM 4OHT before
ﬂow sorting to isolate red cells. e qRT-PCR of mRNA isolated from the cells described in c. n= 3 biological replicates. f Immunoblotting of JAG1 in the cells
indicated. g Quantiﬁcation of SAHFs in IMR90 ER:HRASG12V expressing mRFP co-cultured with the tumour cells indicated for 6 days +100 nM 4OHT. n= 3
biological replicates. h Volcano plots showing regions of altered accessibility in RIS cells co-cultured with MCF7, A549 and Hep3B cells (as in c) relative to RIS
cells cultured alone. Regions that also become more accessible in RIS (red) and NIS (purple) vs. growing are indicated where numbers indicate the total
number of signiﬁcant alterations (log2 fold change <−0.58 or >0.58 and FDR < 0.01) and <−1 indicates the number with a log2 fold change of <−1. i Number
of more accessible regions in RIS (identiﬁed in Fig. 4c) that are repressed by co-culture with MCF7, A549 and Hep3B. b, c, e, g Statistical signiﬁcance
calculated using one-way ANOVA with Tukey’s correction for multiple comparisons; *p≤0.05, **p≤0.01, ***p≤ 0.001, NS = not signiﬁcant
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Non-cell autonomous regulation of SAHFs by tumour cells.
Both HMGA1 and NOTCH1 can act as oncogenes or tumour
suppressors in a context-dependent manner. We reasoned that
the relationship between these two genes might also be important
in the tumour microenvironment and asked whether tumour cells
expressing JAG1 can affect HMGA1 expression and chromatin
structure in adjacent ﬁbroblasts.
To answer this question, we used the Cancer Cell Line
Encyclopedia36 to identify tumour cell lines that express low
(MCF7), medium (A549) and high (Hep3B) levels of JAG1, which
we conﬁrmed by immunoblotting (Fig. 6a). Co-culture of tumour
cell lines with IMR90 cells expressing both ER:HRASG12V and
mRFP1 in the presence of 4OHT was sufﬁcient to repress SAHF
formation in red (RIS) cells in a contact-dependent manner
(Fig. 6b; Supplementary Fig. 7a). The number of SAHF-positive
red cells inversely correlated with the level of JAG1 expressed by
the tumour cell lines (Fig. 6b). Non-autonomous inhibition of
SAHF formation in the co-culture system was completely
abrogated by DAPT, suggesting the effect is dependent on the
canonical NOTCH pathway (Fig. 6b, c). Consistent with our
previous experiments (Fig. 1e, Supplementary Fig. 1e), the
addition of DAPT was sufﬁcient to increase the percentage of
SAHF-positive IMR90 cells above basal levels both in mono-
culture (Fig. 6c) and co-culture (Fig. 6b).
To determine whether tumour cell lines can induce
NOTCH1 signalling and repress HMGAs non-autonomously,
we repeated the co-cultures and isolated the IMR90 ER:
HRASG12V mRFP1 cells using ﬂow cytometry (Fig. 6d,
Supplementary Fig. 7b). We found a dramatic upregulation of
the canonical NOTCH1 target gene HEYL and a concurrent
downregulation of HMGA1 and HMGA2 in ﬁbroblasts co-
cultured with JAG1-expressing tumour cells, particularly A549
and Hep3B cells (Fig. 6e). Two other canonical target genes, HES1
and HEY1, were not dramatically upregulated by JAG1-
expressing cell lines (Supplementary Fig. 7c). Although HEYL,
HEY1 and HES1 are known as ‘canonical targets’ of NOTCH,
their transcriptional regulation by NOTCH signalling is highly
complex: for example, unique combinations of, or interactions
between, NOTCH ligands and receptors can provide preferential
induction of certain targets37,38. Different tumour cell lines might
differentially express other NOTCH ligands (in addition to JAG1)
or other NOTCH pathway modulators, conferring additional
complexity.
To further determine whether the effect described above is
JAG1-dependent, we used CRISPR-Cas9 technology to generate
A549 cells with bi-allelic knockout of endogenous JAG1. Two
knockout clones were isolated; clone 1 had a 5 bp deletion in the
ﬁrst allele and a 1 bp deletion in the second allele while clone 2
had a 1 bp deletion in the ﬁrst allele and a 14 bp deletion in the
second allele (Supplementary Fig. 7d). A control clone was
generated by transfecting cells with Cas9 but omitting guide RNA
(−gRNA control cells). We found that both clones 1 and 2 had
reduced JAG1 levels by immunoblotting (Fig. 6f) and cell-surface
JAG1 (plus JAG2) levels by ﬂow cytometry (Supplementary
Fig. 7e). Proliferation was not substantially altered in JAG1-
knockout cells relative to control or parental cells (Supplementary
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Fig. 7f). In contrast to control or parental A549 cells, co-culture of
JAG1-knockout A549 cells with red IMR90 ER:HRASG12V cells in
the presence of 4OHT had little effect on SAHF formation in red
(RIS) cells (Fig. 6g).
In addition to JAG1-knockout A549 cells, we generated MCF7
cells containing DOX-inducible JAG1 fused to mVenus (JAG1-
mVenus). By immunoblotting, we observed low-level expression
of JAG1-mVenus even in the absence of DOX, likely caused by
‘leaky’ transcription (Supplementary Fig. 7g). Addition of 10 ng/
mL of DOX to the culture was sufﬁcient to induce JAG1 to
comparable levels as those observed endogenously in Hep3B cells
(Supplementary Fig. 7g). Co-culture of MCF7 cells containing
inducible JAG1 with red IMR90 ER:HRASG12V cells was
sufﬁcient to reduce the number of SAHF-positive red cells even
in the absence of DOX (reﬂecting the slightly increased levels of
JAG1) and completely repress SAHF formation in red cells in the
presence of DOX (Supplementary Fig. 7h). While we cannot
exclude the effects of other cell-contact-mediated signalling
pathways on chromatin structure, our data together demonstrate
that JAG1-expressing tumour cells can repress SAHF formation
in adjacent senescent cells in a JAG1-dependent manner.
Non-cell autonomous regulation of chromatin accessibility.
Next, we asked whether tumour cell lines could repress the for-
mation of RIS-driven accessible regions in ﬁbroblasts, as was the
case for ectopic N1ICD (Fig. 5b). Utilising ﬂow cytometry, we
isolated 4OHT-induced IMR90 ER:HRASG12V mRFP1 cells after
co-culture with tumour cell lines and performed ATAC-seq
(Fig. 6d). We found that 66% (29,507), 72% (32,364) and 75%
(33,581) of RIS-driven accessible regions were signiﬁcantly
repressed by co-culture with MCF7, A549 and Hep3B cells,
respectively (Fig. 6h, i; Supplementary Fig. 8a, b). Co-culture with
MCF7, A549 or Hep3B cells induced opening of 6948, 10,303 and
14,064 NIS-driven accessible regions, respectively (Fig. 6h). These
data correlated well with the ability of the tumour cell lines to
repress SAHFs in adjacent IMR90 (Fig. 6b) and the JAG1 levels
expressed by each line (Fig. 6a). RIS-driven accessible regions
repressed by co-culture with tumour cell lines overlapped well
with each other and with regions repressed by ectopic N1ICD
(Supplementary Fig. 8c, d). These data suggest that tumour cells
expressing JAG1 can dramatically alter the chromatin landscape
of adjacent stromal cells at the nucleosome level.
HEYL and HMGA1 anti-correlate in multiple tumour types. If
NOTCH1 signalling inhibits HMGA1 in vivo, we would expect
an anti-correlation between NOTCH1 activity and HMGA1
expression in human tumour samples. To test this, we ﬁrst per-
formed a pan-tissue-type analysis using expression microarray
data from the R2 database (http://r2.amc.nl) by comparing the
expression of HMGA1 and canonical NOTCH1 target genes.
When Z-score expression values were analysed in 36,846 human
samples, we observed a signiﬁcant negative correlation between
HMGA1 and HEYL (R=−0.356, p < 0.0001) and HMGA1 and
HEY1 (R=−0.281, p < 0.0001), but no correlation between
HMGA1 and HES1 (Supplementary Fig. 9a, b, c). Interestingly,
HEYL and HEY1, but not HES1, were also signiﬁcantly upregu-
lated in IMR90 ﬁbroblasts co-cultured with JAG1-expressing
RPE1 cells (Fig. 3g). To study the prognostic importance of this
relationship, we used the web-based tool KM-plotter39,40 and
found that patients with low HMGA1 or high HEYL have a sig-
niﬁcantly better prognosis in lung adenocarcinoma, but not in
lung squamous cell carcinoma (SCC) (Supplementary Fig. 9d, e),
suggesting that the relationship between these proteins may have
prognostic value in certain types of cancer. High HEY1 levels
were prognostic of better overall survival in both types of lung
cancer patient (Supplementary Fig. 9d, e).
As microarray data can be dependent on the quality of the
probe used, we analysed the co-expression of HMGA1 and HEYL
or HEY1 using RNA-seq data generated by The Cancer Genome
Atlas (TCGA) Research Network41 (http://cancergenome.nih.
gov). There was a signiﬁcant negative correlation between
HMGA1 and HEYL in the majority of tumour types analysed
(Fig. 7a) and a particularly strong anti-correlation in lung SCC
(Fig. 7b) (R=−0.4842; p= < 0.0001). When TCGA patients with
lung SCC were categorised based on expression into ‘HMGA1
high–HEYL low’ and ‘HMGA1 low–HEYL high’ tumours,
patients in the former category had a better overall survival
(Fig. 7c) (p= 0.00316). We also found a signiﬁcant negative
correlation between HMGA1 and HEY1 in various cancer types,
which were not completely overlapping with those where
HMGA1 and HEYL anti-correlate (Supplementary Fig. 10a). For
example, they were not negatively correlated in lung SCC and the
expression of these two genes was not prognostic of patient
survival (Supplementary Fig. 10b, c). However, kidney renal clear
cell carcinoma showed the strongest negative correlation between
HMGA1 and HEY1 and their expression patterns were indicative
of prognosis (Supplementary Fig. 10a, d, e). Together, these data
demonstrate that an anti-correlation between HMGA1 expression
and NOTCH1 activity is evident in cancer and that this
correlation can be prognostic of patient outcome.
Discussion
In the current study, we provide evidence for NOTCH-mediated
‘lateral modulation’ of chromatin structure at the microscopic
and nucleosome scales. While RIS cells form prominent SAHFs at
the microscopic scale13,42, at the nucleosome scale we observed a
robust increase in chromatin accessibility. Both SAHFs and RIS-
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Fig. 8 NOTCH1 signalling mediates non-cell autonomous regulation of
chromatin structure at the microscopic and nucleosome scale. Lateral
induction of NOTCH1 activity in a signal-receiving cell by JAG1 on the
surface of an adjacent cell (including cancer cells) can drive NIS. NIS cells
form unique chromatin-accessible regions and microscopically
‘smoothened’ chromatin. In the context of RIS, non-cell autonomous
activation of NOTCH1 signalling can repress the formation of AT-rich RAS-
driven accessible regions at the nucleosome level and SAHF formation at
the microscopic level. Mechanistically, N1ICD represses HMGA1, which is
responsible for SAHF formation and at least partially for the formation of
ectopic-accessible chromatin in RIS cells
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driven accessibility can be inhibited by N1ICD-mediated
repression of HMGA1 (Fig. 8). While the essential and struc-
tural role for HMGA1 in SAHF formation is well established16, its
role in chromatin accessibility is unclear. HMGA proteins com-
pete with Histone-H1 for linker DNA and thus affect chromatin
compaction, as demonstrated by techniques such as ﬂuorescence
recovery after photo bleaching and MNase digestion assays43,44.
Our data, using sequencing technology, demonstrate that
HMGA1 effects the formation of ectopic accessible regions,
potentially by facilitating the binding of other transcription fac-
tors, such as C/EBPβ, identiﬁed here through motif analysis of
RIS-driven accessible regions. It is known that chromatin acces-
sibility is an indicator of developmental maturity45 and that
cancer cells acquire ectopic accessible regions45,46. For example,
during the metastasis of small cell lung cancer, a dramatic
increase in chromatin accessibility at distal regulatory elements
allows tumour cells to co-opt pre-programmed gene expression
programmes, providing a growth advantage32. Thus our data
raise a possibility that HMGA1 can drive pluripotency and cancer
in part by modulating chromatin accessibility. It will be important
to understand how HMGA1 facilitates both chromatin ‘opening’
at the nucleosome scale and the formation of SAHFs and to
determine whether the two are related. We wonder whether the
subset of HMGA1-dependent regions that are gene distal could
have structural rather than regulatory functionality.
Chromatin accessibility was also increased in NIS cells
although these were often at distinct loci. Unlike RIS cells, NIS
cells do not form SAHFs and are instead characterised by chro-
matin ‘smoothening’. The mechanisms of chromatin smoothen-
ing and formation of NIS-driven accessible regions, and whether
these events are related, remains unclear. Note, although knock-
down of HMGA1 blocked formation of SAHFs and many RIS-
driven accessible regions, it was not sufﬁcient to induce NIS-like
chromatin smoothening or NIS-like chromatin accessibility, thus
NOTCH signalling modulates chromatin by both HMGA1-
dependent and -independent mechanisms (Fig. 5b, c). One pos-
sible mechanism through which NOTCH modulates chromatin is
through directed histone acetylation47–50. N1ICD activates gene
transcription by recruiting histone acetyl-transferases11 and was
more recently shown to drive rapid and widespread deposition of
H3K56ac51, which is known to be associated with nucleosome
assembly, particularly in DNA replication and repair52.
NOTCH signalling can be transiently activated during stress-
induced senescence (e.g. oncogene- and DNA damage-induced
senescence)9 but also plays important roles during development
and in cancer, thus ‘lateral induction’ of NOTCH activity through
JAG1 could affect chromatin structure in various biologically
relevant scenarios involving epithelial and/or ﬁbroblast cells. Here
we extend our analysis to the more speciﬁc ‘epithelial-ﬁbroblast’
scenario that might mirror the cancer microenvironment where
epithelial tumour cells are in active communication with stromal
cells through the NOTCH1–JAG1–HMGA1 signalling axis.
Consistently, using the Pten-null mouse model of prostate cancer,
Su and colleagues53 demonstrated that JAG1 expression in
tumour cells facilitates the formation of a ‘reactive stroma’, which
plays an important role in tumour development. It will be
important to test whether chromatin structure is altered in the
stroma of such tumours and whether this is dependent on
HMGA1 repression. In NOTCH-ligand-expressing tumours,
targeting chromatin-modifying enzymes in the stromal com-
partment may present a unique therapeutic opportunity to alter
the tumour niche.
Methods
Cell culture. IMR90 HDFs (ATCC) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM)/10% foetal calf serum (FCS) in a 5% O2/5% CO2 atmosphere.
hTERT-RPE1 cells (ATCC) were grown in DMEM-F12/10% FCS in a 5% O2/5%
CO2 atmosphere. MCF7, H1299, A549 and Hep3B cells (ATCC) were grown in
DMEM/10% FCS in a 5% CO2 atmosphere. Cell identity was conﬁrmed by STR
(short tandem repeats) genotyping. Cells were regularly tested for mycoplasma
contamination and always found to be negative.
Co-cultures were set-up at a cell number ratio of 1:1 and performed in DMEM/
10% FCS in a 5% O2/5% CO2 atmosphere. For transwell experiments, IMR90 cells
were plated in the bottom chamber and hTERT-RPE1 or tumour cells were plated
into the top chamber of a Corning 12-well Transwell plate (CLS3460 Sigma).
The following compounds were used in cultures: 100 nM 4-hydroxytamoxifen
(4OHT) (Sigma), 10 µM DAPT (Sigma), 100 µM etoposide (Sigma), between 10
and 1000 ng/mL doxycycline (DOX) (Sigma) as indicated in individual ﬁgures.
Vectors. The following retroviral vectors were used: pLNCX (clontech) ER:
HRASG12V30; pWZL–hygro for N1ICD–FLAG (residues 1758–2556 of human
NOTCH19) and mRFP1; pLPC-puro for dnMAML1-mVenus (residues 12–74 of
human MAML1)9, mRFP1, rThy1-mRFP1, JAGGED1-mVenus and mVenus;
pQCXIH-i for DOX-inducible N1ICD-FLAG9; MSCV-puro for miR30 shHMGA1
(shHMGA1 target sequence 5′-ATGAGACGAAATGCTGATGTAT-3’16); and
pCLIIPi54 for pCLIIPi JAGGED1-mVenus.
To generate pLPC-puro rThy1-mRFP1, we ﬁrst PCR cloned mRFP into pLPC-
puro (pLPC-puro-x-mRFP, where x denotes cloning sites to express mRFP-fusion
proteins). The CDS of rat-Thy1 was PCR ampliﬁed from cDNA (a gift from M. de
la Roche, CRUK CI, UK), removing the stop codon, before cloning into pLPC-
puro-x-mRFP. To generate pLPC-JAGGED1-mVenus, the CDS of human
JAGGED1 was ampliﬁed using cDNA derived from N1ICD-expressing IMR90
cells, removing the stop codon, before cloning into pLPC-puro-x-mVenus. To
generate pCLIIPi (DOX-inducible) JAG1-mVenus, JAGGED1-mVenus was sub-
cloned using PCR into pCLIIPi.
Flow cytometry. Analysis of ectopic JAG1-mVenus expression was conducted by
ﬂow cytometry9. Cells were ﬁxed using 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS) and stained with anti-JAG1-APC (FAB1726A, R&D Systems,
1:10) or isotype control antibody (IC0041A, R&D Systems, 1:10) before analysis on
a FACSCalibur ﬂow cytometer (Becton Dickenson). Flow data were further ana-
lysed using FlowJo v10.
MACS and FACS. MACS of rThy1-expressing cells was performed using CD90.1
microbeads (130-094-523, Miltenyl Biotec) according to the manufacturer’s
instructions. Fluorescence-activated cell sorting (FACS) was performed using an
Inﬂux (Becton Dickenson) ﬂow cytometer.
Fluorescence microscopy. Analysis was performed as previously described16.
Brieﬂy, cells were plated onto #1.5 glass coverslips the day before ﬁxation to achieve
approximately 60% conﬂuence. Cells were ﬁxed in 4% (v/v) PFA and permeabilised
with 0.2% (v/v) Triton X-100 in PBS with DAPI. Coverslips were mounted onto
Superfrost Plus slides (4951, Thermo Fisher) with Vectashield Antifade mounting
medium (H-1000, Vector Laboratories Ltd.). Images were obtained using a Leica
TCS SP8 microscope with a HC PL APO CS2 1.4NA 100× oil objective (Leica
Microsystems). At least 30 nuclei were captured per biological replicate and con-
dition before Fiji55 was used to calculate nuclear area, standard deviation and
maximum intensity of DAPI signal per nucleus. Speciﬁcally, the DAPI channel was
duplicated, desaturated and a threshold applied using the Otsu method before holes
were ﬁlled and the ‘analyse particles’ function was used to create a region of interest
per nucleus for measurement in the original DAPI-stained image. SADS were
visualised by DNA-ﬂuorescence in situ hybridisation as previously described15
using ﬂuorescent probes that target the α-satellite repeat sequence (5′-
CTTTTGATAGAGCAGTTTTGAAACACTCTTTTTGTA-
GAATCTGCAAGTGGATATTTGG-3′). The percentage of SAHF- and SADS-
positive cells was counted by scoring at least 200 cells per replicate and condition.
Quantitative reverse transcription-PCR. RNA was prepared using the Qiagen
RNeasy Plus Kit (74136, Qiagen) according to the manufacturer’s instructions and
reverse-transcribed to cDNA using the Applied Biosystems High-Capacity Reverse
Transcription Kit (43-688-13, Thermo Fisher). Relative expression was calculated
as previously described16 on an Applied Biosystems Quantstudio 6 by the 2−ΔΔCt
method56 using β-actin (ACTB) as an internal control. The following primers were
used:
ACTB forward: 5′-GGACTTCGAGCAAGAGATGG-3′
ACTB reverse: 5′-AGGAAGGAAGGCTGGAAGAG-3′
HEYL forward: 5′-CTCCAAAGAATCTGTGATGCCAC-3′
HEYL reverse: 5′-CCAGGGACAATGAAAGCAAGTTC-3′
HEY1 forward: 5′-CCGCTGATAGGTTAGGTCTCATTTG-3′
HEY1 reverse: 5′-TCTTTGTGTTGCTGGGGCTG-3′
HES1 forward: 5′-ACGTGCGAGGGCGTTAATAC-3′
HES1 reverse: 5′-ATTGATCTGGGTCATGCAGTTG-3′
HMGA1 forward: 5′-GAAAAGGACGGCACTGAGAA-3′
HMGA1 reverse: 5′-TGGTTTCCTTCCTGGAGTTG-3′
HMGA2 forward: 5′-AGCGCCTCAGAAGAGAGGA-3′
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HMGA2 reverse: 5′-AACTTGTTGTGGCCATTTCC-3′
Protein quantiﬁcation by immunoblotting. Immunoblotting was performed
using sodium dodecyl sulphate-polyacrylamide gel electrophoresis gels using the
following antibodies: anti-β-actin (Sigma, A5441, 1:10,000); anti-HRAS (Calbio-
chem, OP-23, 1:500); anti-NOTCH1 (Cell Signaling, 4380, 1:500); anti-HES1 (Cell
Signalling, 11988, 1:1000); anti-FLAG (Cell Signaling, 2368, 1:1000), anti-HMGA1
(Cold Spring Harbor Labs, #37, 1:1000); anti-HMGA1 (Abcam, Ab4078, 1:1000);
anti-HMGA2 (Cold Spring Harbor Labs, #24, 1:1000); anti-GFP (Clontech 632377,
1:1000); and anti-JAG1 (Cell Signaling, 2155, 1:1000). Images of uncropped
immunoblots are included in Supplementary Fig. 11.
ATAC-seq. ATAC-seq samples were generated as previously31 using 100,000
IMR90 cells and 13 cycles of PCR ampliﬁcation. Samples were size selected between
170 and 400 bp (in order to isolate ‘nucleosome free’ and ‘mono-nucleosome’
fragments) using SPRIselect beads (B23319, Beckman Coulter) before single-end
sequencing to generate 75 bp reads on the NextSeq-500 platform (Illumina).
ChIP-seq. Chromatin immunoprecipitation (ChIP) was performed as previously
described using 20 µg of sonicated chromatin57 from growing and RIS IMR90 ER:
HRASG12V cells and 5 µg of anti-H3K27ac antibody (Clone CMA30958) or 5 µg of
H3K4me1 antibody (Clone CMA30258). Libraries were prepared using the NEB-
Next Ultra II DNA Library Prep Kit for Illumina (37645, New England Biolabs)
according to the manufacturer’s instructions except that size selection was per-
formed after PCR ampliﬁcation using SPRIselect beads (B23319, Beckman Coul-
ter). Samples were sequenced single-end using 50 bp reads on the HiSeq-2500
platform (Illumina).
RNA-seq. RNA-seq data was generated from IMR90 ER:HRASG12V cells expres-
sing a short-hairpin targeting the 3′ UTR of human HMGA1 (RIS+shHMGA1).
RNA was puriﬁed as above and quality checked using the Bioanalyser eukaryotic
total RNA nano series II chip (Agilent). mRNA-seq libraries were prepared from
six biological replicates of each condition using the TruSeq Stranded mRNA
Library Prep Kit (Illumina) according to the manufacturer’s instructions and
sequenced using the HiSeq-2500 platform (Illumina).
Generation of genome-edited JAG1 knockout clones. The following CRISPR
guides were designed against Exon 2 of JAG1 (NM_000214.2) (Supplementary
Fig. 7d):
sgJAG1_2.1: 5′-AGTCCCGCGTCACGGCCGGG-3′ (PAM:GGG) and
sgJAG1_2.2: 5′-CGCGGGACTGATACTCCTTG-3′ (PAM:AGG).
Oligonucleotides (Sigma Aldrich) were cloned into pSpCas9(BB)-2A-GFP59.
pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid #
48138). Guide cutting efﬁciency was determined in A549 cells using the T7 assay
(New England Biolabs, following manufacturer’s instructions). To generate
independent, non-sister clonal cell lines, A549 cells were transiently transfected
(Lipofectamine 3000, Thermo Fisher Scientiﬁc) with PX458-empty (control),
PX458-sgJAG1_2.1 and PX458-sgJAG2.2, and single cell was cloned 96 h post-
transfection by FACS (BD FACSAria II). gDNA was extracted from each clone
(Extracta DNA Prep, VWR, 95091-025) and Exon 2 of JAG1 was ampliﬁed by PCR
(FastStart HF System (Sigma Aldrich, 3553361001)) using the following primers
(universal Fluidigm tag in lower case, JAG1-speciﬁc sequence in upper case)):
Forward: 5′-acactgacgacatggttctaca-GAGCTGCAGAACGGGAACT-3′;
Reverse: 5′-tacggtagcagagacttggtct-CTTGAGGTTGAAGGTGTTGC-3′.
Amplicons were diluted 1:150 and re-ampliﬁed with Fluidigm barcoding
primers (incorporating a unique sample barcode and Illumina P5 and P7 adapter
sequences), pooled and subjected to sequencing (Illumina MiSeq platform). The
AmpliconSeq analysis pipeline was used for data processing and variant calling.
Brieﬂy, reads were aligned against the reference genome (GRCh38) using BWA-
MEM60 and variants were called using two methods (VarDict61 and GATK
HaplotypeCaller62). Consensus variants and their effects on CRISPR clones were
then calculated. All clones used in this paper were STR genotyped and conﬁrmed as
free from mycoplasma.
RNA-seq analysis. Reads were mapped to the human reference genome hg19 with
the STAR (version 2.5.0b) aligner63. Low-quality reads (mapping quality <20) as
well as known adapter contaminations were ﬁltered out using Cutadapt (version
1.10.0)64. Read counting was performed using Bioconductor packages Rsubread34
and differential expression analysis with edgeR33,34. The conditions were con-
trasted against the growing samples. Genes were identiﬁed as differentially
expressed with a FDR (false discovery rate) cut-off of 0.01 and an absolute value of
logFC (log2 of the fold change) >0.58.
ChIP-seq and ATAC-seq analysis. ChIP-seq and ATAC-seq reads were mapped
to the human reference genome (hg19) with BWA (version 0.7.12)60. Low-quality
reads (mapping quality <20) as well as known adapter contaminations were ﬁltered
using Cutadapt (version 1.10.0)64, and reads mapping to the ‘blacklisted’ regions
identiﬁed by ENCODE65 were further removed. Average fragment size was
determined using the ChIPQC Bioconductor package66, and peak calling was
performed with MACS2 (version 2.1.0)67, using fragment size as an extension size
(--extsize) parameter. High-conﬁdence peak sets for each condition were identiﬁed
separately using only those peak regions that were present in at least two replicates.
Differential accessibility analysis. THOR35 and edgeR33,34 were used to identify
differentially accessible regions between conditions. For the comparisons ‘NIS vs.
growing’ and ‘RIS vs. growing’, the intersect of regions detected by THOR and
edgeR was taken. This approach gave us a robust set of regions that are altered in
RIS and NIS conditions. For other comparisons where volcano plots were gener-
ated, edgeR was used to interrogate how different genetic and cell-culture
manipulations effect the alterations detected in RIS.
edgeR33,34 was used on a merged set of growing, RIS, NIS, N+RIS, shHMGA1
and RIS/shHMGA1 high-conﬁdence ATAC-seq peak sets (present in at least two
replicates of a single condition) to identify regions of differential accessibility
between conditions. We utilised the TMM method implemented in edgeR for
normalisation and dispersion calculation of the replicated samples. The results
were further ﬁltered based on FDR < 0.05 and logFC ≥ 0.58 or ≤−0.58.
THOR is a Hidden Markov Model based approach that utilises all mapped
reads and identiﬁes the differentially accessible regions between two conditions.
THOR was used in parallel with edgeR to identify the differences between the
conditions using our pre-computed normalisation factors (see section 'Generation
of normalised coverage ﬁles') to normalise between samples. Regions were further
ﬁltered using a −log(p-value) cut-off of 10.
Annotating differentially accessible regions. Bedtools intersect (v2.26.0)68 was
used to identify regions annotated as 'unchanged' by extracting high-conﬁdence
peaks in the 'growing' condition that did not intersect with regions that become
more or less accessible in the NIS and/or RIS conditions (relative to the growing
condition). The rest of the categories (open or closed in RIS or NIS) were identiﬁed
based on the differential accessibility analysis compared to growing using the
intersect of THOR and edgeR as described above. Regions displaying altered
chromatin accessibility were mapped to genomic annotations or repeat regions
using bedtools v2.26.068. For the genomic annotations, we used TSSs from the
FANTOM database69, repeats from repeatMasker (UCSC genome browser) and
other genomic features (exons, introns, UTRs, etc.) were extracted from the UCSC
Table Browser. The enhancers were identiﬁed based on our own H3K4me1 and
H3K27ac histone mark ChIP-seq data sets; all regions that had peaks in both of
these marks in either growing or RIS cells were considered as enhancers.
Intersecting consensus peaks and generating Venn diagrams. The Homer
(v3.12)70 command ‘mergePeaks’ with default settings and the output options
‘–venn’ and ‘–preﬁx’ were used to generate values for plotting Venn diagrams and
associated bed ﬁles for further analysis. Only literal overlaps (overlapping by 1 bp)
were considered. Venn diagrams were plotted using the R package ‘Venneuler’
(https://cran.rproject.org/web/packages/venneuler/index.html).
Calculating proximity to genes and GC percentage. To calculate the distance of
consensus peaks from TSSs and GC percentage of accessible regions, the Homer
(v3.12)70 command ‘annotatePeaks.pl’ was used with default settings and the
output option ‘-CpG’.
Gene enrichment analysis. Altered accessible regions within 500 bp of a gene TSS
were identiﬁed using Homer as described above. Gene enrichment analysis was
performed using the GO Biological Process 2015 annotation provided on the web-
tool ‘Enrichr’71 (http://amp.pharm.mssm.edu/Enrichr/).
Generation of normalised coverage ﬁles. A previously described approach was
used to generate scaling factors for each ATAC-seq condition relative to others32.
Brieﬂy, we reasoned that the enrichment of reads within ATAC-seq peaks con-
taining TSSs of genes that are both expressed (logCPM >mean logCPM) and have
low variance between conditions (−0.14 < logFC < 0.14) by RNA-seq should not
vary, unless there are differences in ATAC-seq sample quality, preparation or
sequencing. By reanalysing our previously published IMR90 RNA-seq data9
together with newly generated RNA-seq samples for RIS+shHMGA1 cells, we
identiﬁed 589 genes that ﬁt these criteria. We counted the reads from the ATAC-
seq samples that map to these speciﬁc genes using Rsubread34 and computed
scaling factors based on the mean counts for each condition separately. Normalised
coverage ﬁles (bigWig) were generated by pooling reads from all of the replicates
and applying the calculated scaling factors using the ‘genomecov’ function in
bedtools, sorting the resulting normalised bedGraph ﬁles and then converting them
to bigWigs using the ‘bedGraphToBigWig’ function from UCSC.
Generation of clustered heatmaps. Heatmaps were generated using normalised
coverage of peaks (+/−2.5 kb) representing novel accessible regions (regions with
signiﬁcantly altered chromatin accessibility in RIS or NIS relative to growing cells)
with k-means clustering using the deepTools package72.
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PCA analysis and correlation heatmaps. Samples were normalised with the pre-
calculated normalisation factors (as described above in ‘Generation of normalised
coverage ﬁles’), and reads from all growing, RIS, NIS, N+RIS, shHMGA1 and RIS/
shHMGA1 consensus peak sets (present in at least two replicates across all of the
samples) were extracted and used in the PCA analysis and the correlation analysis
of data sets. Pearson correlation was calculated between samples based on these
normalised read counts and correlation heatmaps were generated with pheatmap
(http://CRAN.R-project.org/package=pheatmap) and WPGMA clustering. PCA
plots were generated using ggplot273.
Reads from publicly available ATAC-seq and DNase-seq data sets74–77
(references and NIH Epigenomics Roadmap Initiative) were extracted from the
same regions; however, since these were not included in normalisation factor
calculation, standard CPM normalisation was used for Supplementary Fig. 4c.
Volcano plots. edgeR calculated statistical parameters (logFC and logFDR) were
used to visualise differentially accessible regions in RIS (red) and NIS (purple)
compared to growing cells in the comparisons indicated. Plots were generated
using ggplot273.
Motif enrichment analysis. Meme-ChIP suite (version 4.12.0), together with
Hocomoco (version 11) human and mouse PWMs, was used to detect motif
enrichment in a 600 bp region centred at the peak summit.
TCGA analysis. We analysed the expression levels of NOTCH-associated genes in
the publicly available RNA sequencing data generated by the TCGA Research
Network: http://cancergenome.nih.gov/41.
Computational analysis and statistical testing of the Next-Generation
Sequencing data was conducted using the R statistical programming language78.
Filtered and log2-normalised RNA expression data along with all available clinical
data were downloaded from the GDAC ﬁrehose database (run:
stddata_2015_06_01) for each gene of interest from the relevant cancer-speciﬁc
collections.
Correlation testing for associations between expressed genes was performed
using the cor.test function in R to calculate the Pearson’s product moment
correlation coefﬁcient and test for signiﬁcant deviation from no correlation.
Plotting of TCGA data was performed using the ggplot2 R package73. Survival
analysis was performed using the survminer and survival79 R packages.
Kaplan–Meier estimated survival curves were constructed using the TCGA clinical
data. Statistical testing of differences between survival curves used the G-rho family
of tests, as implemented in the survdiff function of the survival package.
Statistics and reproducibility. No statistical method was used to predetermine
sample size and experiments were not randomised. Statistical analyses were con-
ducted using the Graphpad Prism 6 and R statistical software, except for TCGA
data analysis (which was as described in the methods above). One-way analysis of
variance with Tukey’s correction for multiple comparisons was used for data sets
with >2 conditions. Two-sample t-tests were used for two-condition comparisons.
The statistical tests were justiﬁed as appropriate based on the number of samples
compared and the assumed variance within populations. A p-value of <0.05 was
used to indicate statistical signiﬁcance.
Data availability. The RNA-seq, ChIP-seq and ATAC-seq data generated for this
study have been deposited at the Gene Expression Omnibus (GEO) with the
accession number GSE103590. Gene expression data from RIS, NIS and N+RIS is
previously published9 and available under GEO accession number GSE72404.
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